3//SEC Filing
Shire Human Genetic Therapies, Inc. 3
Accession 0000950103-18-007853
CIK 0001693415other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 8:26 PM ET
Size
5.9 KB
Accession
0000950103-18-007853
Insider Transaction Report
Form 3
Shire Human Genetic Therapies, Inc.
10% Owner
Holdings
- 6,895,325
Common Stock
Footnotes (1)
- [F1]These shares are owned directly by Shire Human Genetic Therapies, Inc., which is an indirect wholly owned subsidiary of Shire plc. Shire plc is an indirect beneficial owner of the reported securities.
Documents
Issuer
Translate Bio, Inc.
CIK 0001693415
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001745009
Filing Metadata
- Form type
- 3
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 8:26 PM ET
- Size
- 5.9 KB